CORAL BIOME is led by a multidisciplinary team including PhDs and researchers in marine biology, in cell biology, and in chemistry and is surrounded by internationally recognized experts in oncology and immunology.

Our history / founders

CORAL BIOME was founded in 2011 by Frédéric Gault (aquaculture engineer) and Dr. Yvan Perez (senior researcher at Aix-Marseille University), two friends and passionate aquarists. They envisioned a biotechnology company dedicated to unraveling the precious therapeutic potential hidden in corals. CORAL BIOME therefore focusses on the identification of marine natural products to develop new drugs to treat cancer and other major health issues. Part of the corals grown are sold for research to other institutions, and for aquarium trade (online shop here).

Since their selection in 2010 in the Luminy biotech nursery, they surrounded themselves with interdisciplinary PhDs and a network of collaborators, among them internationally renowned experts in Cancerology and Immunology.

Board of directors

Carole Valenti

Pharm.D, Chief Development Officer.

Doctor of Pharmacy and Chemical Engineer, Carole Valenti has spent 20 years in pharmaceutical industry in France and in United Kingdom, mainly in drug development areas. She brings to CORAL BIOME a broad knowledge in chemical and pharmaceutical development activities from preclinical studies to market coupled with a strong expertise in pharmaceutical legislation and regulation. Within the direction team, Carole oversees drug development programs to convert our coral active compounds into promising drug candidates.

Frédérique Gault

Engineer, Chief Executive Officer.

With over 5 years of experience in biotechnology company direction, he is dedicated to the CORAL BIOME project and implements his vision since 2009. Beside Frédéric Gault is also an aquaculture engineer who gained extensive background in coral farming and trade of marine species. He holds a certificate of capacity, delivered by the departmental direction of population protection allowing maintenance, culture and sales of animals under international regulation (convention on international trade in endangered species, CITES)

Sandrine Courtès

Ph.D, Chief Scientific Officer.

After her master’s of Cellular and Molecular Biology at Ecole Normale Supérieure (ENS Lyon), Sandrine Courtès conducted a doctorate in Marseilles and a post-doctorate in the USA on neural stem cells. She then managed an international research consortium and gained experience in scientific communication, negotiation and strategic decisions. Those 10 years of experience in research and science management are a strong asset to strategically coordinate our scientific projects to promote discoveries.

Team

Mathieu Ferry

Mathieu Ferry

Engineer

Mathieu Ferry holds a master degree in oceanography at the Aix-Marseille University. He is responsible for aquaculture and sales and is also working on the DNA barcoding of coral species of interest and the extraction of new cytotoxic compounds.

Andréa Meriot

Andréa Meriot

Engineer

Andréa Meriot holds a master degree in oceanography at the Aix-Marseille University. She is responsible for aquaculture and oversees development and optimization of new culture techniques as well as set-up and management of a quality assurance system.